Practical Guidance for the Multidisciplinary Team on Therapeutics Targeting Protein Degradation Pathways in NHL

Content Format:

Slideset

Credit Type:

--

Credits:

--
Key Studies in Lymphomas and CLL: Independent Coverage of ASH 2023

Content Format:

Text Module

Credit Type:

AAPA | ACPE | AMA | ANCC

Credits:

1.00
Conference to Clinic: Expert Analysis of the 2023 ASH Top Abstracts

Content Format:

Video

Credit Type:

AAPA | ACPE | AMA | ANCC

Credits:

4.75
Conference to Clinic: Lymphoma Updates 2023

Content Format:

Slideset

Credit Type:

--

Credits:

--
An Expert’s Guide to ASH 2023: Preview of the Top Abstracts

Content Format:

Conference Coverage

Credit Type:

--

Credits:

--
Current Advances in Relapsed/Refractory MCL: Expert Guidance for Community Hematology Care Teams

Content Format:

Video

Credit Type:

AAPA | ACPE | AMA | ANCC

Credits:

1.00
Current Advances in Relapsed/Refractory MCL: Expert Guidance for Community Hematology Care Teams

Content Format:

Slideset

Credit Type:

--

Credits:

--
Interactive Decision Support Tool: MCL Expert Treatment Guidance

Content Format:

Tool

Credit Type:

--

Credits:

--
Acclimating Practice to the Current Treatment Landscape in Follicular Lymphoma: Emerging Evidence and Recent Results

Content Format:

Video

Credit Type:

AMA

Credits:

1.50
ExpressPoints Acclimating Practice to the Current Treatment Landscape in FL: Emerging Evidence and Recent Results

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Recent Updates in the Management of Relapsed/Refractory Follicular Lymphoma

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Newer Immunotherapy Options for Relapsed/Refractory Follicular Lymphoma

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
ExpressPoints: Breakthrough Therapeutics for CLL and Other B-Cell Malignancies: Focus on BTK Inhibitors From Development to Clinical Integration

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Overview of Treatment for Mantle Cell Lymphoma

Content Format:

Conference Coverage

Credit Type:

--

Credits:

--
Review of Current and Emerging BTK Inhibitors

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Aggressive B-Cell Lymphomas: Clinical Application of New Advances in Community Practice

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Chronic Lymphocytic Leukemia: Applying the Latest Data in Community Practice

Content Format:

Multimedia

Credit Type:

ACPE | AMA | ANCC

Credits:

1.00
Chronic Lymphocytic Leukemia: Applying the Latest Data in Community Practice

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Key Studies in Hematologic Malignancies: Independent Conference Coverage of the 2021 ASCO Scientific Meeting

Content Format:

Conference Coverage

Credit Type:

AMA

Credits:

1.25
An Expert’s Guide to ASCO 2021: A Preview of the Top Abstracts

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Interactive Decision Support Tool: Expert Treatment Recommendations for Patients With Newly Diagnosed or Relapsed/Refractory Follicular Lymphoma

Content Format:

Tool

Credit Type:

--

Credits:

--
Expert Answers to Frequently Asked Questions on BTK Inhibitors for Treatment of CLL

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
ExpressPoints: Addressing the Medical Need in CLL: How BTK Inhibitors Are Improving Outcomes

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Addressing the Medical Need in CLL: How BTK Inhibitors Are Improving Outcomes

Content Format:

Multimedia

Credit Type:

AMA

Credits:

2.00
Overview of the BCR Pathway and Use of BTK Inhibitors in CLL

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Addressing the Medical Need in CLL: Selecting First-line Therapy

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
My Perspective on 3 Questions I Am Asked on BTK Inhibitors for CLL

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Hematologic Malignancies: A Review of Key Clinical Studies

Content Format:

Text Module

Credit Type:

AMA

Credits:

1.25
ExpressPoints: Critical Advances in CLL Treatment

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Implementing Critical Advances in CLL in Communty Practices: Downloadable Slides

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
How We Use BTK Inhibitors to Treat CLL, MCL, MZL, and Waldenström Macroglobulinemia

Content Format:

Text Module

Credit Type:

ACPE | AMA | ANCC

Credits:

1.00
BTK Inhibitor Therapy: Delving Into Evolving Topics, Critical Aspects of Management, and Practice-Changing Data

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
An Expert’s Guide to ASCO 2020: A Preview of the Top Abstracts

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
How I Use BTK Inhibitors to Treat My Patients With CLL

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Frequently Asked Questions About BTK Inhibitor Use in B-Cell Malignancies

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Advancing the Role of BTK Inhibitors in B-Cell Malignancies: Expert Guidance to Refine Clinical Management Strategies

Content Format:

Multimedia

Credit Type:

AMA

Credits:

2.75
Practical Case Discussions: BTK inhibitor Therapy for MCL

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
B-Cell Malignancies—Expert Guidance on BTK Inhibitors for Today’s Clinic

Content Format:

Multimedia

Credit Type:

AMA

Credits:

2.00
Optimizing the Use of BTK Inhibitors in B-Cell Malignancies

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
What’s New Regarding Frontline Combination Regimens in CLL

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--